# id: 156621
# generation: 91
# extra edges: []
# score: 128.0 / 128.0
# following constraints: True
# complexity: 45

targets,	factors
AKT,	ERBB3 | PDK1 | mTOR
EGF,	EGF
ERBB1,	EGF & !erlotinib & !pertuzumab
ERBB2,	ERBB2 & !erlotinib & !pertuzumab & !trastuzumab | ERBB3 & !pertuzumab & !trastuzumab
ERBB3,	ERBB3 & !erlotinib & !pertuzumab | HRG & !erlotinib & !pertuzumab
ERK1_2,	EGF | ERK1_2 | MEK1_2 | pertuzumab
HRG,	HRG
MEK1_2,	ERBB1 | ERBB2 | MEK1_2
PDK1,	ERBB2 | ERBB3 | MEK1_2 | PDK1
PKCa,	PKCa | PLCg
PLCg,	EGF | ERBB1 | ERBB2 | PLCg
erlotinib,	erlotinib
mTOR,	AKT | pertuzumab
p70S6K,	AKT | ERK1_2
pertuzumab,	pertuzumab
trastuzumab,	trastuzumab
